Novanta (NASDAQ:NOVT) Releases Earnings Results, Beats Estimates By $0.03 EPS

Novanta (NASDAQ:NOVT) released its earnings results on Monday. The technology company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.78 by $0.03, FiscalAI reports. Novanta had a return on equity of 13.11% and a net margin of 5.35%.The firm had revenue of $257.71 million for the quarter, compared to analysts’ expectations of $253.40 million. During the same quarter in the previous year, the business posted $0.74 EPS. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. Novanta updated its FY 2026 guidance to 3.500-3.650 EPS and its Q2 2026 guidance to 0.810-0.860 EPS.

Novanta Price Performance

Novanta stock traded down $1.46 during mid-day trading on Wednesday, reaching $157.73. 201,358 shares of the company were exchanged, compared to its average volume of 429,071. The firm has a market cap of $5.62 billion, a PE ratio of 114.11 and a beta of 1.62. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.69 and a quick ratio of 2.80. The company has a fifty day simple moving average of $126.50 and a 200-day simple moving average of $125.75. Novanta has a 12 month low of $98.27 and a 12 month high of $165.56.

Insider Activity

In other news, CEO Matthijs Glastra sold 6,500 shares of the company’s stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $130.05, for a total transaction of $845,325.00. Following the completion of the sale, the chief executive officer owned 56,761 shares of the company’s stock, valued at approximately $7,381,768.05. This represents a 10.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert Buckley sold 9,957 shares of the company’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of $116.77, for a total value of $1,162,678.89. Following the sale, the chief financial officer owned 96,616 shares of the company’s stock, valued at $11,281,850.32. The trade was a 9.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,880 shares of company stock valued at $2,208,476 in the last ninety days. 1.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Danske Bank A S acquired a new stake in Novanta in the third quarter valued at $40,000. Van ECK Associates Corp increased its stake in shares of Novanta by 17.2% in the third quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock valued at $163,000 after buying an additional 239 shares during the period. O Shaughnessy Asset Management LLC bought a new position in shares of Novanta during the fourth quarter worth about $219,000. EntryPoint Capital LLC acquired a new position in shares of Novanta in the fourth quarter worth approximately $261,000. Finally, Corient Private Wealth LLC bought a new stake in Novanta in the fourth quarter valued at approximately $275,000. Institutional investors own 98.35% of the company’s stock.

Wall Street Analyst Weigh In

NOVT has been the subject of several analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. Robert W. Baird lifted their price objective on shares of Novanta from $144.00 to $173.00 and gave the company an “outperform” rating in a research report on Wednesday. Wall Street Zen lowered shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Finally, Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $173.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.